肿瘤细胞免疫治疗疗效影响因素研究进展

被引：14

作者：

刘涛

沈杰

何凤

卢斌

项方

机构：

[1] 第三军医大学新桥医院·肿瘤生物治疗中心

来源：

西部医学 | 2013年 / 25卷 / 09期

关键词：

细胞免疫治疗; 抗肿瘤; 临床应用; 疗效;

D O I：

暂无

中图分类号：

R730.51 [免疫疗法];

学科分类号：

100108 [医学免疫学];

摘要：

肿瘤免疫治疗近年来发展迅猛,被认为是继手术、放射治疗、化学治疗之后,对肿瘤有明确效果的又一重要治疗方法,广泛应用于多种恶性肿瘤的治疗。但目前肿瘤免疫治疗的临床应用还没有统一的标准,其总体疗效并不十分理想,在肿瘤治疗中处于辅助地位。肿瘤细胞免疫治疗临床疗效与患者体内的肿瘤负荷大小、输注免疫细胞数量与活性、输入途径以及放化疗等密切相关。本文对以DC/CIK细胞免疫治疗为主的肿瘤免疫治疗疗效影响因素研究进展进行综述。

引用

页码：1433 / 1436

页数：4

共 21 条

[1]

Efficacy of adjuvant immunotherapy with cytokine-induced killer cells in patients with locally advanced gastric cancer [J].

Shi, Liangrong ;

Zhou, Qi ;

Wu, Jun ;

Ji, Mei ;

Li, Guojun ;

Jiang, Jingting ;

Wu, Changping .

CANCER IMMUNOLOGY IMMUNOTHERAPY, 2012, 61 (12) :2251-2259

[2]

Combining cytokine-induced killer cells with vaccination in cancer immunotherapy: More than one plus one? [J].

Thanendrarajan, Sharmilan ;

Nowak, Michael ;

Abken, Hinrich ;

Schmidt-Wolf, Ingo G. H. .

LEUKEMIA RESEARCH, 2011, 35 (09) :1136-1142

[3]

Unexpected High Response Rate to Traditional Therapy after Dendritic Cell-Based Vaccine in Advanced Melanoma: Update of Clinical Outcome and Subgroup Analysis.[J].Laura Ridolfi;Massimiliano Petrini;Laura Fiammenghi;Anna Maria Granato;Valentina Ancarani;Elena Pancisi;Emanuela Scarpi;Massimo Guidoboni;Giuseppe Migliori;Stefano Sanna;Francesca Tauceri;Giorgio Maria Verdecchia;Angela Riccobon;Ruggero Ridolfi;Bernhard Fleischer.Clinical and Developmental Immunology.2011,

[4]

Cord blood-derived cytokine-induced killer cells biotherapy combined with second-line chemotherapy in the treatment of advanced solid malignancies.[J].Qi Niu;Wei Wang;Yong Li;Shaowen Qin;Yu Wang;Guangyu Wan;Jingzhi Guan;Wenhua Zhu.International Immunopharmacology.2010, 4

[5]

Dendritic cell-activated cytokine-induced killer cells enhance the anti-tumor effect of chemotherapy on non-small cell lung cancer in patients after surgery [J].